Dunhill Financial’s VanEck Pharmaceutical ETF PPH Stock Holding History

Dunhill Financial’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$89K	Buy	813 +2	+0.2%	+$207	0.02%	235
2026 Q1	$84.3K	Sell	811 -3,215	-80%	-$342K	0.02%	237
2025 Q4	$415K	Buy	4,026 +2,040	+103%	+$198K	0.1%	76
2025 Q3	$179K	Sell	1,986 -847	-30%	-$74.2K	0.05%	142
2025 Q2	$249K	Buy	+2,833	New	+$246K	0.07%	98

Other funds holding PPH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return

AWC

Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Dunhill Financial's PPH Position: Q2 2026 in Review

Dunhill Financial increased its VanEck Pharmaceutical ETF (PPH) stake by 0.25% in Q2 2026, buying an estimated $207 and bringing the position to 813 shares worth $89K. The position accounts for 0.02% of the portfolio, ranked #235.

Dunhill Financial first reported a position in PPH in Q2 2025 and has held it in 5 quarters since. The position peaked at $415K in Q4 2025. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

Dunhill Financial held 813 shares of VanEck Pharmaceutical ETF worth $89K as of Q2 2026.
Dunhill Financial bought 2 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $207.
VanEck Pharmaceutical ETF made up 0.02% of Dunhill Financial's portfolio in Q2 2026, its #235 holding.
Dunhill Financial first reported a position in VanEck Pharmaceutical ETF in Q2 2025 and has held it in 5 quarters since.
Dunhill Financial's VanEck Pharmaceutical ETF position peaked at $415K in Q4 2025.
148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Dunhill Financial's 13F filing for Q2 2026, filed 7 Aug 2026.